Literature DB >> 6109226

Effects of exogenous insulin, glucagon, and somatostatin on islet hormone secretion in the perfused chicken pancreas.

R N Honey, M B Fallon, G C Weir.   

Abstract

The effects of exogenous insulin were examined in the isolated perfused chicken pancreas with the duodenum excluded. At low background glucose (50 mg/dl), exogenous insulin infused at a concentration of 20,000 microU/ml elicited clear stimulation of somatostatin secretion while simultaneously inhibiting glucagon release. When the background glucose concentration was elevated to 750 mg/dl, exogenous insulin, had no effect on either somatostatin or glucagon release. When graded doses of exogenous insulin were infused into the chicken pancreas at low background glucose, low concentrations (200 microU/ml) had little effect on somatostatin or glucagon release, but higher concentrations (2000 and 20,000 microU/ml) had clear effects on both somatostatin and glucagon secretion. Glucagon infused at 100 ng/ml stimulated both insulin and somatostatin release. When somatostatin was infused at 25 ng/ml, clear inhibition of glucagon was seen with insulin inhibited to a lesser extent. This study supports the notion of a negative feedback relation between B and D-cells of the pancreatic islets and suggests a paracrine mediation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6109226     DOI: 10.1016/0026-0495(80)90152-3

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  9 in total

1.  LIM-homeodomain transcription factor Isl-1 mediates kisspeptin's effect on insulin secretion in mice.

Authors:  Juan Chen; Rui Fu; Yan Cui; Jirong Pan; Yushan Li; Xiaoxin Zhang; Sylvia M Evans; Sheng Cui; Jiali Liu
Journal:  Mol Endocrinol       Date:  2014-06-23

2.  The alpha cell response to glucose change during perfusion of anti-insulin serum in pancreas isolated from normal rats.

Authors:  H Maruyama; M Tominaga; G Bolli; L Orci; R H Unger
Journal:  Diabetologia       Date:  1985-11       Impact factor: 10.122

3.  In vivo inhibition of glucagon secretion by paracrine beta cell activity in man.

Authors:  C M Asplin; T L Paquette; J P Palmer
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

Review 4.  Paracrine signaling in islet function and survival.

Authors:  Sean M Hartig; Aaron R Cox
Journal:  J Mol Med (Berl)       Date:  2020-02-17       Impact factor: 4.599

5.  Relationship of glucagon suppression by insulin and somatostatin to the ambient glucose concentration.

Authors:  A Starke; T Imamura; R H Unger
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

6.  Insulin within islets is a physiologic glucagon release inhibitor.

Authors:  H Maruyama; A Hisatomi; L Orci; G M Grodsky; R H Unger
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

7.  Intercellular Communication in the Islet of Langerhans in Health and Disease.

Authors:  Xue W Ng; Yong H Chung; David W Piston
Journal:  Compr Physiol       Date:  2021-06-30       Impact factor: 8.915

8.  Paracrine regulation of somatostatin secretion by insulin and glucagon in mouse pancreatic islets.

Authors:  Berit Svendsen; Jens J Holst
Journal:  Diabetologia       Date:  2020-10-12       Impact factor: 10.122

Review 9.  The somatostatin-secreting pancreatic δ-cell in health and disease.

Authors:  Patrik Rorsman; Mark O Huising
Journal:  Nat Rev Endocrinol       Date:  2018-07       Impact factor: 43.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.